Earnings History Data for Organogenesis Holdings Inc. (ORGO) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Organogenesis Holdings Inc.

Organogenesis is a leading regenerative medicine company focused on the development, manufacture and commercialization of solutions for the Advanced Wound Care and Surgical & Sports Medicine markets.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
12-11-2024	AH		ORGO	Organogenesis Holdings Inc.	434.85	0.09	-0.02	0.02		4.41	0.96 (27.83%)	3.61	0.16 (4.64%)	2.12 - 4.70	2,380,493	360,000	13,076
Organogenesis announces $130M private placement offering [11/12/2024 4:10 PM] Organogenesis Reports Positive Interim Analysis of Second Phase 3 Clinical Trial of ReNu for Knee Osteoarthritis [Nov-11-24 05:05PM]
08-08-2024	AH		ORGO	Organogenesis Holdings Inc.	343.36	-0.13	-0.02	0.04	Organogenesis Holdings GAAP EPS of -$0.13, revenue of $130.2M beats by $8.9M [8/8/2024 4:27 PM]	2.57	-0.05 (-1.91%)	2.72	0.10 (3.82%)	1.96 - 4.70	786,150	440,000	5,672
Organogenesis Holdings GAAP EPS of -$0.13, revenue of $130.2M beats by $8.9M [8/8/2024 4:27 PM] Organogenesis files for mixed shelf offering of up to $250M [8/8/2024 6:26 PM]
09-05-2024	AH		ORGO	Organogenesis Holdings Inc.	321.99	-0.02	-0.03	-0.02	Organogenesis Holdings GAAP EPS of -$0.02 beats by $0.01, revenue of $110M beats by $8.94M [5/9/2024 4:13 PM]	3.05	0.77 (33.77%)	2.37	0.09 (3.95%)	1.96 - 4.70	3,311,777	1,460,000	2,684
Organogenesis Holdings GAAP EPS of -$0.02 beats by $0.01, revenue of $110M beats by $8.94M [5/9/2024 4:13 PM]
29-02-2024	AH		ORGO	Organogenesis Holdings Inc.	460.82	N/A	-0.01	0.06	Organogenesis Holdings GAAP EPS of $0.00 in-line, revenue of $99.7M misses by $9.35M [2/29/2024 4:21 PM]	2.92	-0.65 (-18.35%)	3.40	-0.17 (-4.76%)	1.79 - 4.70	2,338,770	480,000	2,293
Organogenesis Holdings GAAP EPS of $0.00 in-line, revenue of $99.7M misses by $9.35M [2/29/2024 4:21 PM]
09-11-2023	AH		ORGO	Organogenesis Holdings Inc.	295.45	0.02	0.01	0.04	Organogenesis Holdings GAAP EPS of $0.02, revenue of $108.5M [11/9/2023 4:27 PM]	2.19	0.22 (11.17%)	2.13	0.16 (8.12%)	1.79 - 4.50	2,020,781	1,700,000	21,461
Organogenesis Holdings GAAP EPS of $0.02, revenue of $108.5M [11/9/2023 4:27 PM]
09-08-2023	AH		ORGO	Organogenesis Holdings Inc.	485.67	0.04	0.02	0.09	Organogenesis Holdings GAAP EPS of $0.04 beats by $0.01, revenue of $117.3M beats by $2.2M [8/9/2023 4:12 PM]	2.74	-0.65 (-19.17%)	2.37	-1.02 (-30.09%)	1.79 - 5.33	3,495,318	1,050,000	64,399
Organogenesis Holdings GAAP EPS of $0.04 beats by $0.01, revenue of $117.3M beats by $2.2M [8/9/2023 4:12 PM] Organogenesis tumbles after pulling 2023 guidance [8/10/2023 1:34 PM]
10-05-2023	AH	4:05 PM ET (May 10)	ORGO	Organogenesis Holdings Inc.	282.03	-0.02	0.00	0.01	Organogenesis Holdings reports Q1 results, raises FY 2023 revenue guidance [5/10/2023 4:37 PM]	2.88	0.78 (37.38%)	2.32	0.22 (10.55%)	1.79 - 6.53	5,321,623	1,000,000	8,458
Organogenesis Holdings reports Q1 results, raises FY 2023 revenue guidance [5/10/2023 4:37 PM] Organogenesis surges ~30% as Wound Care drives Q1 revenue; raises FY23 outlook [5/11/2023 12:30 PM]
01-03-2023	AH	4:05 PM ET (Mar 1)	ORGO	Organogenesis Holdings Inc.	328.60	0.06	0.00	0.41	Organogenesis Holdings reports Q4 results, introduces FY 2023 revenue guidance [3/1/2023 4:29 PM]	2.70	0.42 (18.42%)	2.28	0.0 (0.00%)	2.20 - 9.27	1,738,865	820,000	21,996
Organogenesis Holdings reports Q4 results, introduces FY 2023 revenue guidance [3/1/2023 4:29 PM] Organogenesis' reports positive interim analysis of Phase 3 ReNu trial for knee pain [3/2/2023 6:30 AM]
09-11-2022	AH	4:05 PM ET (Nov 9)	ORGO	Organogenesis Holdings Inc.	429.31	0.04	0.06	0.09	Organogenesis Holdings GAAP EPS of $0.00, revenue of $116.9M, guidance below consensus [11/9/2022 4:20 PM]	2.62	-0.47 (-15.37%)	2.60	-0.49 (-15.86%)	2.23 - 11.43	2,231,955	420,000	42,069
Organogenesis Holdings GAAP EPS of $0.00, revenue of $116.9M, guidance below consensus [11/9/2022 4:20 PM] Organogenesis Holdings Inc. Reports Third Quarter 2022 Financial Results [Nov-09-22 04:05PM] Organogenesis Holdings (NASDAQ:ORGO) shareholders have endured a 72% loss from investing in the stock a year ago [Nov-09-22 07:18AM]
09-08-2022	AH	4:05 PM ET (Aug 9)	ORGO	Organogenesis Holdings Inc.	693.43	0.09	0.08	0.15	Organogenesis Holdings reports Q2 earnings; narrows FY22 guidance [8/9/2022 5:05 PM]	4.82	-1.19 (-19.88%)	5.30	-0.71 (-11.79%)	4.62 - 17.50	2,892,186	770,000	7,875
Organogenesis Holdings reports Q2 earnings; narrows FY22 guidance [8/9/2022 5:05 PM] Organogenesis Holdings Inc. Reports Second Quarter 2022 Financial Results [Aug-09-22 04:05PM]
10-05-2022	AH	4:05 PM ET (May 10)	ORGO	Organogenesis Holdings Inc.	801.55	0.01	0.05	0.07	Organogenesis Holdings GAAP EPS of $0.00 misses by $0.05, revenue of $98.12M beats by $2.4M [5/10/2022 4:16 PM]	5.88	0.36 (6.42%)	5.75	0.22 (3.98%)	5.30 - 19.75	2,066,304	1,070,000	11,098
Organogenesis Holdings GAAP EPS of $0.00 misses by $0.05, revenue of $98.12M beats by $2.4M [5/10/2022 4:16 PM] Lacklustre Performance Is Driving Organogenesis Holdings Inc.'s (NASDAQ:ORGO) 28% Price Drop [May-10-22 06:05AM] Organogenesis (ORGO) Q1 Earnings Lag Estimates [May-10-22 05:35PM] Organogenesis Holdings Inc. Reports First Quarter 2022 Financial Results [May-10-22 04:05PM] Organogenesis Holdings Inc. (ORGO) Q1 2022 Earnings Call Transcript [May-11-22 05:00AM]
01-03-2022	AH	4:05 PM ET (Mar 1)	ORGO	Organogenesis Holdings Inc.	940.39	0.41	0.08	0.15	Organogenesis Holdings GAAP EPS of $0.39 beats by $0.29, revenue of $128.56M beats by $4.19M [3/1/2022 4:26 PM]	8.77	1.53 (21.16%)	8.37	1.13 (15.61%)	6.37 - 24.34	3,513,814	1,210,000	8,628
Organogenesis Holdings GAAP EPS of $0.39 beats by $0.29, revenue of $128.56M beats by $4.19M [3/1/2022 4:26 PM] Organogenesis gains the most in over a year after strong Q4 earnings beat [3/2/2022 10:30 AM] Organogenesis Holdings Inc. Reports Fourth Quarter and Fiscal Year 2021 Financial Results; Introduces Fiscal Year 2022 Guidance [Mar-01-22 04:05PM] Organogenesis (ORGO) Tops Q4 Earnings and Revenue Estimates [Mar-01-22 07:25PM] Organogenesis Holdings Inc. (ORGO) Q4 2021 Earnings Call Transcript [Mar-01-22 10:00PM] Why Organogenesis Holdings Stock Blasted 21% Higher Today [Mar-02-22 05:48PM]
09-11-2021	AH	4:00 PM ET (Nov 9)	ORGO	Organogenesis Holdings Inc.	1,470	0.09	0.06	0.19	Organogenesis Holdings EPS beats by $0.03, beats on revenue [11/9/2021 4:20 PM]	11.03	-0.37 (-3.25%)	10.91	-0.49 (-4.30%)	3.51 - 24.34	1,515,700	920,000	2,218
Organogenesis Holdings EPS beats by $0.03, beats on revenue [11/9/2021 4:20 PM] ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Organogenesis Holdings Inc. and Encourages Investors with Losses to Contact the Firm [Nov-08-21 10:00AM] Organogenesis Holdings Inc. to Participate in the Credit Suisse 30th Annual Healthcare Conference [Nov-08-21 07:30AM] Organogenesis Holdings Inc. Reports Third Quarter and First Nine Months 2021 Financial Results [Nov-09-21 04:05PM] Organogenesis Investor Alert [Nov-09-21 06:31PM] Organogenesis (ORGO) Tops Q3 Earnings and Revenue Estimates [Nov-09-21 06:25PM] Organogenesis Holdings Inc (ORGO) Q3 2021 Earnings Call Transcript [Nov-10-21 09:01AM] ONGOING INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Organogenesis Holdings Inc. and Encourages Investors with Losses to Contact the Firm [Nov-10-21 09:55AM] Organogenesis Shareholder Alert [Nov-10-21 06:38PM]
09-08-2021	AH	4:05 PM ET (Aug 9)	ORGO	Organogenesis Holdings Inc.	1,930	0.15	0.06	-0.05	Organogenesis Holdings EPS beats by $0.10, beats on revenue [8/9/2021 4:20 PM]	15.01	0.19 (1.28%)	17.30	2.48 (16.73%)	3.36 - 24.34	1,042,274	770,000	7,120
Organogenesis Holdings EPS beats by $0.10, beats on revenue [8/9/2021 4:20 PM] Organogenesis Holdings Inc. Reports Second Quarter and First Half 2021 Financial Results [Aug-09-21 04:03PM] Organogenesis Holdings Inc. Announces New $200 Million Credit Agreement with Silicon Valley Bank [Aug-09-21 04:01PM] Organogenesis (ORGO) Q2 Earnings and Revenues Beat Estimates [Aug-09-21 05:25PM] Organogenesis Holdings Inc (ORGO) Q2 2021 Earnings Call Transcript [Aug-10-21 03:01AM]
10-05-2021	AH	4:05 PM ET (May 10)	ORGO	Organogenesis Holdings Inc.	2,640	0.07	-0.04	-0.16	Organogenesis Holdings EPS beats by $0.09, beats on revenue [5/10/2021 4:40 PM]	17.92	-1.37 (-7.10%)	17.40	-1.89 (-9.80%)	3.01 - 24.34	1,243,249	630,000	7,057
Organogenesis Holdings EPS beats by $0.09, beats on revenue [5/10/2021 4:40 PM] Organogenesis Appoints Jon Giacomin to Board of Directors [May-10-21 07:30AM] Organogenesis Holdings, Inc. to Host Earnings Call [May-10-21 02:45PM] Organogenesis Holdings Inc. Reports First Quarter 2021 Financial Results [May-10-21 04:05PM] CORRECTING and REPLACING Organogenesis Holdings Inc. Reports First Quarter 2021 Financial Results [May-10-21 05:13PM] Organogenesis (ORGO) Surpasses Q1 Earnings and Revenue Estimates [May-10-21 05:35PM] Organogenesis Holdings Inc (ORGO) Q1 2021 Earnings Call Transcript [May-11-21 05:30AM]
16-03-2021	AH	4:05 PM ET (Mar 16)	ORGO	Organogenesis Holdings Inc.	2,260	0.15	0.12	-0.04	Organogenesis Holdings EPS beats by $0.03, beats on revenue [3/16/2021 4:24 PM]	17.87	0.81 (4.75%)	16.50	-0.56 (-3.28%)	2.47 - 18.41	712,434	592,165	2,657
Organogenesis Holdings EPS beats by $0.03, beats on revenue [3/16/2021 4:24 PM] Organogenesis Holdings, Inc. to Host Earnings Call [Mar-16-21 02:45PM] Organogenesis Holdings Inc. Reports Fourth Quarter and Fiscal Year 2020 Financial Results; Introduces Fiscal Year 2021 Guidance [Mar-16-21 04:05PM] Organogenesis (ORGO) Q4 Earnings and Revenues Top Estimates [Mar-16-21 05:35PM] Recap: Organogenesis Holdings Q4 Earnings [Mar-16-21 04:41PM] Organogenesis Holdings Inc (ORGO) Q4 2020 Earnings Call Transcript [Mar-16-21 11:00PM] Brokers Are Upgrading Their Views On Organogenesis Holdings Inc. (NASDAQ:ORGO) With These New Forecasts [Mar-17-21 10:49AM]
09-11-2020	AH	4:05 PM ET (Nov 9)	ORGO	Organogenesis Holdings Inc.	411.13	0.19	-0.06	-0.12	Organogenesis Holdings EPS beats by $0.26, beats on revenue [11/9/2020 4:43 PM]	4.35	0.20 (4.82%)	4.44	0.29 (6.99%)	2.47 - 8.34	344,234	103,202	19,231

10-08-2020	AH	4:05 PM ET (Aug 10)	ORGO	Organogenesis Holdings Inc.	409.58	-0.05	-0.12	-0.11	Organogenesis Holdings EPS beats by $0.18, beats on revenue [8/10/2020 4:18 PM]	4.19	0.34 (8.83%)	4.28	0.43 (11.17%)	2.47 - 8.34	156,996	79,702	799